OOIR: Observatory of International Research

Papers

(The H4-Index of Cancer and Metastasis Reviews is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Gastric cancer: a comprehensive review of current and future treatment strategies	299
The role of fibroblast activation protein in health and malignancy	175
Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?	156
Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?	156
Molecular epidemiology and diagnostics of KRAS mutations in human cancer	147
FOXO transcription factor family in cancer and metastasis	139
CDK7 inhibitors as anticancer drugs	99
Lung cancer identification: a review on detection and classification	97
Molecular and cellular mechanisms underlying brain metastasis of breast cancer	77
Regulation of breast cancer metastasis signaling by miRNAs	74
Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners	72
Glioma: molecular signature and crossroads with tumor microenvironment	65
Current therapy of KRAS-mutant lung cancer	62
Checkpoint inhibitor therapy for metastatic triple-negative breast cancer	57
Wnts and the hallmarks of cancer	57
Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer	56
Secreted frizzled-related protein 2: a key player in noncanonical Wnt signaling and tumor angiogenesis	51
Emerging links between endosomal pH and cancer	49
The emerging role of Wnt5a in the promotion of a pro-inflammatory and immunosuppressive tumor microenvironment	48
Collagen biology making inroads into prognosis and treatment of cancer progression and metastasis	48
Caveolin-1 function at the plasma membrane and in intracellular compartments in cancer	46
Neuroblastoma and the epigenome	46
The adipocyte microenvironment and cancer	43
Targeting KRAS in pancreatic cancer: new drugs on the horizon	41
Interaction between adipose tissue and cancer cells: role for cancer progression	41

Lipid metabolism reprogramming in renal cell carcinoma	38
The obesity-breast cancer link: a multidisciplinary perspective	37
The comprehensive landscape of miR-34a in cancer research	37
Gastrointestinal stromal tumor: a review of current and emerging therapies	36
Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy	34
The role of lipid species in membranes and cancer-related changes	33
Targeting the cytoskeleton against metastatic dissemination	33
An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression	32